A: Hey there! Have you heard any interesting news lately?
B: Nah, nothing much. What's up?
A: I just read this thing about a new breakthrough for cervical cancer treatment!
B: Oh, really? Tell me more!
A: So, researchers at Chiba University created a vaccine that fights off cervical cancer cells!
B: Wow, that sounds amazing! And who's affected by this disease in Japan?
A: About 10,000 women per year develop cervical cancer. Current treatments like surgery and radiation therapy can cause aftereffects and higher risks of infertility or miscarriage.
B: That sounds tough... I hope something better comes along soon.
A: This vaccine is made from a substance derived from the human papillomavirus, which causes cervical cancer. It's given nasally and can trigger immune cells to attack the cancer cells.
B: Incredible! Have they tried it out on anything?
A: They tested it on mice, and it destroyed the cancer cells! They also confirmed that it induces immune cells to the cervix in monkeys.
B: That's a great start! So, are they planning to test it on humans soon?
A: Yes! They announced their findings in a US science journal and hope this will lead to a new treatment method without surgery or radiation therapy.
B: I can't wait to hear more about it! Keep me posted, okay?
A: Of course! They confirmed the vaccine's effectiveness on mice and other subjects, so they'll now test whether it works in humans and aim to put it into practical use. Fingers crossed!
B: Nah, nothing much. What's up?
A: I just read this thing about a new breakthrough for cervical cancer treatment!
B: Oh, really? Tell me more!
A: So, researchers at Chiba University created a vaccine that fights off cervical cancer cells!
B: Wow, that sounds amazing! And who's affected by this disease in Japan?
A: About 10,000 women per year develop cervical cancer. Current treatments like surgery and radiation therapy can cause aftereffects and higher risks of infertility or miscarriage.
B: That sounds tough... I hope something better comes along soon.
A: This vaccine is made from a substance derived from the human papillomavirus, which causes cervical cancer. It's given nasally and can trigger immune cells to attack the cancer cells.
B: Incredible! Have they tried it out on anything?
A: They tested it on mice, and it destroyed the cancer cells! They also confirmed that it induces immune cells to the cervix in monkeys.
B: That's a great start! So, are they planning to test it on humans soon?
A: Yes! They announced their findings in a US science journal and hope this will lead to a new treatment method without surgery or radiation therapy.
B: I can't wait to hear more about it! Keep me posted, okay?
A: Of course! They confirmed the vaccine's effectiveness on mice and other subjects, so they'll now test whether it works in humans and aim to put it into practical use. Fingers crossed!
Similar Readings (5 items)
Japanese medical institutions face rubella vaccine shortage
University of Tokyo building facility for clinical vaccine trials
Novavax approved in Japan, expected to be available in late May
Tests show Omicron vaccines 71% effective in preventing infection
Japan's first domestically produced coronavirus vaccine now available to public
Summary
Researchers at Chiba University developed a vaccine for cervical cancer, which affects approximately 10,000 women annually in Japan. The vaccine is derived from the human papillomavirus and can trigger immune cells to attack cancer cells without causing aftereffects or higher risks of infertility
Statistics
251
Words1
Read CountDetails
ID: 9b154361-b10d-4b15-80dc-b99bddf76ace
Category ID: conversation_summary
URL: https://www3.nhk.or.jp/nhkworld/en/news/20251209_34/#conversation
Date: Dec. 9, 2025
Notes: 2025-12-09
Created: 2025/12/09 19:40
Updated: 2025/12/09 20:02
Last Read: 2025/12/09 20:02